Rezolute GAAP EPS of -$0.22 misses by $0.03
Source: SeekingAlpha
2026-02-12 16:38:10 ET
More on Rezolute
- Rezolute: Phase 3 sunRIZE Data For Ersodetug Warrants Downgrade To Sell Rating
- Rezolute, Inc. (RZLT) Discusses Phase 3 sunRIZE Study Results and Challenges in Congenital Hyperinsulinism Transcript
- Rezolute: sunRIZE And upLIFT Trials Could Drive The Next Move
- Rezolute plunges as lead asset fails in late-stage trial
- Seeking Alpha’s Quant Rating on Rezolute
Read the full article on Seeking Alpha
For further details see:
Rezolute GAAP EPS of -$0.22 misses by $0.03
Rezolute Inc.
NASDAQ: RZLT
RZLT Trading
3.41% G/L:
$3.18 Last:
700,949 Volume:
$3.06 Open:
RZLT Latest News
February 12, 2026 04:05:00 pm
Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
February 04, 2026 07:00:00 am
Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
RZLT Stock Data
$291,628,088
79,022,403
1.3%
35
N/A
Biotechnology & Life Sciences
Healthcare
US
Redwood City
